Gossamer Bio, Inc. (GOSS) Q3 2021 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and thank you for standing by. Welcome to the Gossamer Bio Q3 earnings call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1 on your telephone. If you require any further assistance, please press star 0. I would now like to hand the conference over to your speaker today, Mr. Brian Truetto, Financial and Chief Operating Officer. Thank you. Please go ahead. Thank you, Operator, and thank you all for joining us this afternoon. I am joined on today's call by Gossamer Bios Chairman, Co-Founder and Chief Executive Officer Faheem Hasnain, Laura Carter, Gossamer Bios Chief Scientific Officer, and Richard Aranda, Gossamer Bios Chief Medical Officer. Earlier this afternoon, Gossamer Bio issued a press release announcing its financial results for the third quarter ended September 3, 2021, in addition to providing a corporate update. Please note that certain information discussed on this call today is covered under the safe harbor provision of the Private Securities Litigation Reform Act. We caution listeners that during this call, Gossamer management will be making forward-looking statements. Actual results may differ materially from those stated or implied by these forward-looking statements due to risks, and uncertainties associated with the company's business. These four looking statements are qualified by the statements contained in Gossamer's news releases and SEC filings, including in the annual report on Form 10-K and subsequent filings. This conference call also contains time-sensitive information that may be accurate only for a limited period of time. Our ability to meet our guidance, especially that relat...